Advertisement
Screener

SOMAXON PHARMACEUTICALS, INC. Financing Cash Flow

SOMAXON PHARMACEUTICALS, INC. Financing Cash Flow

SOMAXON PHARMACEUTICALS, INC. reported Financing Cash Flow of $2.85 million for the 9-month period ending 2012-09-30, per its 10-Q filed 2012-11-01.

Discontinued › Cash Flow › Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2012-11-01

  • SOMAXON PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for the quarter ending 2011-12-31 was -$14.05M, a 155.83% decline year-over-year.
  • SOMAXON PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for the quarter ending 2011-09-30 was $15.30M, a 33897.78% increase year-over-year.
  • SOMAXON PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for the quarter ending 2011-06-30 was $5.00M.
  • SOMAXON PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for the quarter ending 2011-03-31 was $1.00K.
  • SOMAXON PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for fiscal 2011 was $6.25M, a 92.31% decline from fiscal 2010.
  • SOMAXON PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for fiscal 2010 was $81.27M.
  • SOMAXON PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for fiscal 2009 was -$7.62M.
Period endNet Cash Provided by (Used in) Financing Activities 3 monthNet Cash Provided by (Used in) Financing Activities 6 monthNet Cash Provided by (Used in) Financing Activities 9 monthNet Cash Provided by (Used in) Financing Activities 12 month
2012-09-30$2.85M
10-Q · filed 2012-11-01
2011-12-31-$14.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-09
$1.25M
derived: sum of 2 quarters · filed 2012-11-01
$6.25M
derived: sum of 3 quarters · filed 2012-11-01
$6.25M
10-K · filed 2012-03-09
2011-09-30$15.30M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01
$20.30M
derived: sum of 2 quarters · filed 2012-11-01
$20.30M
10-Q · filed 2012-11-01
$45.47M
derived: sum of 4 quarters · filed 2012-11-01
2011-06-30$5.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08
$5.00M
10-Q · filed 2012-08-08
$30.17M
derived: sum of 3 quarters · filed 2012-08-08
$30.21M
derived: sum of 4 quarters · filed 2012-08-08
2011-03-31$1.00K
10-Q · filed 2012-05-10
$25.17M
derived: sum of 2 quarters · filed 2012-05-10
$25.21M
derived: sum of 3 quarters · filed 2012-05-10
2010-12-31$25.17M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-09
$25.21M
derived: sum of 2 quarters · filed 2012-03-09
$81.27M
10-K · filed 2012-03-09
2010-09-30$45.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04
$56.10M
10-Q · filed 2011-11-04
2010-06-30$56.06M
10-Q · filed 2011-08-03
2009-12-31-$7.62M
10-K · filed 2012-03-09